Tumor Marker Testing Market Competitive Landscape, 2019-2023: Strategic Assessments of Leading Suppliers
This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents.
The assessments include:
- Sales
- Product portfolios
- Distribution tactics
- Technological know-how
- New products in R&D
- Collaborative arrangements
- Business strategies.
- AdnaGen/Alere
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila/Alere
US Hospital Tumor Marker Testing Market Supplier Shares by Test and Strategies Volume and Sales Segment Forecasts Technology and Instrumentation Review Emerging Opportunities
US Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging OpportunitiesThis new report from contains 567 pages
USD 3450 View ReportUK Hospital Tumor Marker Testing Market Supplier Shares by Test and Strategies Volume and Sales Segment Forecasts Technology and Instrumentation Review Emerging Opportunities
UK Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging OpportunitiesThis new report from contains 527 pages
USD 3450 View ReportUS Hospital Tumor Marker Testing Market Supplier Shares by Test and Strategies Volume and Sales Segment Forecasts Technology and Instrumentation Review Emerging Opportunities
US Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging OpportunitiesThis new report from contains 567 pages
USD 3450 View ReportUK Hospital Tumor Marker Testing Market Supplier Shares by Test and Strategies Volume and Sales Segment Forecasts Technology and Instrumentation Review Emerging Opportunities
UK Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging OpportunitiesThis new report from contains 527 pages
USD 3450 View ReportFill The Form For Sample Request